These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
404 related items for PubMed ID: 17444589
21. [Efficacy and safety of infliximab in patients with rheumatoid arthritis]. Zhang W, Shi Q, Wu DH, Bao CD, Yang NP, Li ZG, Zhu P, Zhang X, Huang CB, He DY, Ye ZZ, Tao Y, Fang YF, Gu JR, Wu HX, Sun LY, Yang XY, Huang F, Xu HJ, Zhao DB, Zhang MJ, Zheng Y, Ai MX, Lu J, Zhang FC. Zhonghua Yi Xue Za Zhi; 2009 Jul 21; 89(27):1876-80. PubMed ID: 19953907 [Abstract] [Full Text] [Related]
25. Methotrexate reduces vaccine-specific immunoglobulin levels but not numbers of circulating antibody-producing B cells in rheumatoid arthritis after vaccination with a conjugate pneumococcal vaccine. Kapetanovic MC, Nagel J, Nordström I, Saxne T, Geborek P, Rudin A. Vaccine; 2017 Feb 07; 35(6):903-908. PubMed ID: 28081972 [Abstract] [Full Text] [Related]
28. Sustained benefit in rheumatoid arthritis following one course of rituximab: improvements in physical function over 2 years. Strand V, Balbir-Gurman A, Pavelka K, Emery P, Li N, Yin M, Lehane PB, Agarwal S. Rheumatology (Oxford); 2006 Dec 07; 45(12):1505-13. PubMed ID: 17062648 [Abstract] [Full Text] [Related]
31. A phase I study assessing the safety, clinical response, and pharmacokinetics of an experimental infliximab formulation for subcutaneous or intramuscular administration in patients with rheumatoid arthritis. Westhovens R, Houssiau F, Joly J, Everitt DE, Zhu Y, Sisco D, Van Hartingsveldt B, Mascelli MA, Graham MA, Durez P, Bouman-Thio E. J Rheumatol; 2006 May 07; 33(5):847-53. PubMed ID: 16583466 [Abstract] [Full Text] [Related]
32. Efficacy and safety of etanercept 50 mg twice a week in patients with rheumatoid arthritis who had a suboptimal response to etanercept 50 mg once a week: results of a multicenter, randomized, double-blind, active drug-controlled study. Weinblatt ME, Schiff MH, Ruderman EM, Bingham CO, Li J, Louie J, Furst DE. Arthritis Rheum; 2008 Jul 07; 58(7):1921-30. PubMed ID: 18576334 [Abstract] [Full Text] [Related]
33. Effect of abatacept on the immunogenicity of 23-valent pneumococcal polysaccharide vaccination (PPSV23) in rheumatoid arthritis patients. Migita K, Akeda Y, Akazawa M, Tohma S, Hirano F, Ideguchi H, Kozuru H, Jiuchi Y, Matsumura R, Suematsu E, Miyamura T, Mori S, Fukui T, Izumi Y, Iwanaga N, Tsutani H, Saisyo K, Yamanaka T, Ohshima S, Mori N, Matsumori A, Takahi K, Yoshizawa S, Kawabe Y, Suenaga Y, Ozawa T, Hamada N, Komiya Y, Matsui T, Furukawa H, Oishi K. Arthritis Res Ther; 2015 Dec 10; 17():357. PubMed ID: 26653668 [Abstract] [Full Text] [Related]
34. Adalimumab plus methotrexate improved SF-36 scores and reduced the effect of rheumatoid arthritis (RA) on work activity for patients with early RA. Kimel M, Cifaldi M, Chen N, Revicki D. J Rheumatol; 2008 Feb 10; 35(2):206-15. PubMed ID: 18085743 [Abstract] [Full Text] [Related]
35. Infliximab is associated with improvement in arterial stiffness in patients with early rheumatoid arthritis -- a randomized trial. Tam LS, Shang Q, Li EK, Wang S, Li RJ, Lee KL, Leung YY, Ying KY, Yim CW, Kun EW, Leung MH, Li M, Li TK, Zhu TY, Chui RK, Tseung L, Yu SL, Kuan WP, Yu CM. J Rheumatol; 2012 Dec 10; 39(12):2267-75. PubMed ID: 22984272 [Abstract] [Full Text] [Related]
36. Evolution of antinuclear antibodies and clinical patterns in patients with active rheumatoid arthritis with longterm infliximab therapy. Comby E, Tanaff P, Mariotte D, Costentin-Pignol V, Marcelli C, Ballet JJ. J Rheumatol; 2006 Jan 10; 33(1):24-30. PubMed ID: 16395746 [Abstract] [Full Text] [Related]
37. Pneumococcal vaccine response in psoriatic arthritis patients during treatment with etanercept. Mease PJ, Ritchlin CT, Martin RW, Gottlieb AB, Baumgartner SW, Burge DJ, Whitmore JB. J Rheumatol; 2004 Jul 10; 31(7):1356-61. PubMed ID: 15229957 [Abstract] [Full Text] [Related]
38. Combination of infliximab and methotrexate therapy for early rheumatoid arthritis: a randomized, controlled trial. St Clair EW, van der Heijde DM, Smolen JS, Maini RN, Bathon JM, Emery P, Keystone E, Schiff M, Kalden JR, Wang B, Dewoody K, Weiss R, Baker D, Active-Controlled Study of Patients Receiving Infliximab for the Treatment of Rheumatoid Arthritis of Early Onset Study Group. Arthritis Rheum; 2004 Nov 10; 50(11):3432-43. PubMed ID: 15529377 [Abstract] [Full Text] [Related]
39. Long-term infliximab treatment in rheumatoid arthritis: subsequent outcome of initial responders. Buch MH, Bingham SJ, Bryer D, Emery P. Rheumatology (Oxford); 2007 Jul 10; 46(7):1153-6. PubMed ID: 17478470 [Abstract] [Full Text] [Related]
40. Humoral responses after influenza vaccination are severely reduced in patients with rheumatoid arthritis treated with rituximab. van Assen S, Holvast A, Benne CA, Posthumus MD, van Leeuwen MA, Voskuyl AE, Blom M, Risselada AP, de Haan A, Westra J, Kallenberg CG, Bijl M. Arthritis Rheum; 2010 Jan 10; 62(1):75-81. PubMed ID: 20039396 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]